Status:

UNKNOWN

Predictive Factors for Chronic Rejection in Lung Transplant Recipients: COLT Study

Lead Sponsor:

Nantes University Hospital

Conditions:

Chronic Rejection

Lung Transplantation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Obliterative Bronchiolitis (OB) is the major cause of long-term lung allograft loss for patients with end stage pulmonary diseases like cystic fibrosis. Numerous cells and proteins are implicated in t...

Eligibility Criteria

Inclusion

  • Male or female adults aged ≥ 18 years
  • who have signed an Inform Consent Form
  • double or heart-lung transplant recipients

Exclusion

  • Pregnant or nursing women
  • Patients with concomitant chronic inflammatory disease, independently of acute or chronic rejection or infection

Key Trial Info

Start Date :

September 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2017

Estimated Enrollment :

700 Patients enrolled

Trial Details

Trial ID

NCT00980967

Start Date

September 1 2009

End Date

September 1 2017

Last Update

May 12 2015

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

CHU de Bordeaux

Bordeaux, France, 33604

2

CHU de Grenoble

Grenoble, France, 38700

3

Centre Chirurgical Marie Lannelongue

Le Plessis-Robinson, France, 92350

4

CHU de Lyon

Lyon, France, 69677